pSLQ9926: pHR-PGK-SV40_NLS-dCasMINI-V4-VPR-c- Myc_NLS-mCherry-WPRE Citations (1)

Originally described in: Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing.
Xu X, Chemparathy A, Zeng L, Kempton HR, Shang S, Nakamura M, Qi LS Mol Cell. 2021 Aug 26. pii: S1097-2765(21)00648-1. doi: 10.1016/j.molcel.2021.08.008. PubMed Journal

---

Articles Citing pSLQ9926: pHR-PGK-SV40_NLS-dCasMINI-V4-VPR-c- Myc_NLS-mCherry-WPRE

Articles
Activation of endogenous full-length utrophin by MyoAAV-UA as a therapeutic approach for Duchenne muscular dystrophy. Wu R, Li P, Xiao P, Zhang S, Wang X, Liu J, Sun W, Chang Y, Ai X, Chen L, Zhuo Y, Wang J, Wang Z, Li S, Li Y, Ji W, Guo W, Wu S, Chen Y. Nat Commun. 2025 Mar 10;16(1):2398. doi: 10.1038/s41467-025-57831-5. PubMed

If you have published an article using this material, please email us at to have your article added to this page.